General Information of the Compound
Compound ID
CP0527337
Compound Name
4-[1-(3-methylphenyl)-4-pyrazolo[3,4-d]pyrimidinyl]morpholine
    Show/Hide
Structure
Formula
C16H17N5O
Molecular Weight
295.346
Canonical SMILES
Cc1cccc(c1)-n1ncc2c(ncnc12)N1CCOCC1
    Show/Hide
InChI
InChI=1S/C16H17N5O/c1-12-3-2-4-13(9-12)21-16-14(10-19-21)15(17-11-18-16)20-5-7-22-8-6-20/h2-4,9-11H,5-8H2,1H3
    Show/Hide
InChIKey
MSVZBRIGZKVLLO-UHFFFAOYSA-N
Physicochemical Property
logP
1.96052
Rotatable Bonds
2
Heavy Atom Count
22
Polar Areas
56.07
Hydrogen Bond Donor Count
0
Hydrogen Bond Acceptor Count
6
Complexity
22

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 819343
ChEMBL ID
CHEMBL1606999
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT06101, Latent membrane protein 1
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000006 HEK293 Homo sapiens (Human)  1
1
AC50 = 74044 nM
   TI
   LI
   LO
   TS